EG435337 inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the activity of the EG435337 protein, which is known to play a crucial role in regulating certain cellular processes such as signal transduction, enzymatic function, and intracellular interactions. EG435337 is involved in mediating key steps in cellular pathways that influence various functions, including cell growth, metabolic regulation, and communication between different cellular compartments. The inhibitors work by binding to specific regions of the protein, such as the active catalytic site or allosteric sites that modulate protein conformation and activity. The binding may be competitive, where the inhibitor competes with natural substrates to occupy the active site, or non-competitive, where the inhibitor binds to a distinct location and induces changes in protein conformation that hinder the protein's function. The primary focus in designing EG435337 inhibitors is to achieve high specificity for EG435337, thereby minimizing off-target effects on other proteins or enzymes with similar structures.
Developing EG435337 inhibitors requires a comprehensive understanding of the structural and functional properties of the target protein. Techniques like X-ray crystallography, cryo-electron microscopy (cryo-EM), and nuclear magnetic resonance (NMR) spectroscopy are employed to elucidate the three-dimensional structure of EG435337. These high-resolution structural studies provide insights into the binding pockets, functional domains, and dynamic aspects of the protein that can be targeted for inhibition. Computational modeling, including molecular docking and molecular dynamics simulations, helps predict the interaction between potential inhibitors and EG435337, enabling the optimization of compounds for enhanced binding affinity and selectivity. The design process often includes structure-activity relationship (SAR) analysis, which involves systematically modifying the chemical structure of the inhibitors to fine-tune their properties, such as improving their ability to form specific interactions like hydrogen bonds or hydrophobic contacts with the target protein. The chemical diversity of EG435337 inhibitors allows for different strategies in inhibition, ranging from small organic molecules to larger, more complex structures that may interact with multiple domains of the protein. These compounds are optimized for properties such as solubility, stability, and cellular permeability, ensuring effective modulation of EG435337 activity in biological systems. The development of EG435337 inhibitors represents a combination of structural biology, computational chemistry, and synthetic chemistry aimed at understanding and controlling the role of EG435337 in cellular regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor affecting translation initiation. Rapamycin may indirectly inhibit Eif1ad7 by disrupting the mTOR pathway, which regulates translational initiation. The inhibition of mTOR signaling can influence the function of Eif1ad7 in translation initiation. | ||||||
eIF4E/eIF4G Interaction Inhibitor, 4EGI-1 | 315706-13-9 | sc-202597 | 10 mg | $265.00 | 14 | |
EIF4E/eIF4G interaction inhibitor affecting translation initiation. 4EGI-1 might indirectly impact Eif1ad7 by disrupting the interaction between EIF4E and eIF4G, crucial for translation initiation. This disruption can influence the translation initiation factor activity of Eif1ad7. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $245.00 | 7 | |
mTOR inhibitor affecting translation initiation. Torin1 may indirectly inhibit Eif1ad7 by targeting the mTOR pathway, regulating translational initiation. Inhibition of mTOR signaling can influence the function of Eif1ad7 in translation initiation. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Protein synthesis inhibitor affecting translation initiation. Cycloheximide can indirectly inhibit Eif1ad7 by globally disrupting protein synthesis, including the translation initiation process where Eif1ad7 plays a crucial role in translation initiation factor activity. | ||||||
12(S)-HHT | 54397-84-1 | sc-200969 sc-200969A | 50 µg 250 µg | $332.00 $1665.00 | ||
Protein synthesis inhibitor affecting translation initiation. Homoharringtonine (HHT) can indirectly inhibit Eif1ad7 by globally disrupting protein synthesis, including the translation initiation process where Eif1ad7 plays a crucial role in translation initiation factor activity. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
mTOR inhibitor affecting translation initiation. PP242 may indirectly inhibit Eif1ad7 by targeting the mTOR pathway, regulating translational initiation. Inhibition of mTOR signaling can influence the function of Eif1ad7 in translation initiation. | ||||||
Scutellarin | 27740-01-8 | sc-286767 sc-286767A sc-286767B | 10 mg 25 mg 100 mg | $180.00 $400.00 $525.00 | ||
Translation inhibitor affecting initiation. Scutellarin might indirectly impact Eif1ad7 by influencing translation initiation processes. Its mechanism of action may involve interference with key steps in translation initiation, affecting the activity of Eif1ad7. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
Eukaryotic translation initiation inhibitor. Silvestrol may indirectly inhibit Eif1ad7 by disrupting eukaryotic translation initiation. Its mechanism of action involves inhibiting translation initiation factors, potentially affecting the translation initiation factor activity of Eif1ad7. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Aminoacyl-tRNA analog affecting translation initiation. Puromycin can indirectly inhibit Eif1ad7 by acting as a premature chain terminator during protein synthesis, affecting translation initiation where Eif1ad7 plays a role in translational initiation factor activity. | ||||||
Nifuroxazide | 965-52-6 | sc-204128 sc-204128A | 500 mg 5 g | $203.00 $520.00 | 5 | |
EIF4E/eIF4G interaction inhibitor affecting translation initiation. Nifuroxazide may indirectly impact Eif1ad7 by disrupting the interaction between EIF4E and eIF4G, crucial for translation initiation. This disruption can influence the translation initiation factor activity of Eif1ad7. | ||||||